カテゴリ： 世界, 医療/バイオ, Market Monitor Global

注射用ビアペネムのグローバル市場展望 2023年-2029年：300mg、100mg

■ 英語タイトル：Biapenem for Injection Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14241）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14241
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[注射用ビアペネムのグローバル市場展望 2023年-2029年：300mg、100mg]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の注射用ビアペネム市場規模と予測を収録しています。・世界の注射用ビアペネム市場：売上、2018年-2023年、2024年-2029年
・世界の注射用ビアペネム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の注射用ビアペネム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「300mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

注射用ビアペネムのグローバル主要企業は、Meiji Holdings Co., Ltd、 CSPC、 Simcere Pharmaceutical、 Cisen Pharmaceutical、 CHIATAI TIANQINGなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、注射用ビアペネムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の注射用ビアペネム市場：タイプ別、2018年-2023年、2024年-2029年
世界の注射用ビアペネム市場：タイプ別市場シェア、2022年
・300mg、100mg

世界の注射用ビアペネム市場：用途別、2018年-2023年、2024年-2029年
世界の注射用ビアペネム市場：用途別市場シェア、2022年
・病院、薬局

世界の注射用ビアペネム市場：地域・国別、2018年-2023年、2024年-2029年
世界の注射用ビアペネム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における注射用ビアペネムのグローバル売上、2018年-2023年
・主要企業における注射用ビアペネムのグローバル売上シェア、2022年
・主要企業における注射用ビアペネムのグローバル販売量、2018年-2023年
・主要企業における注射用ビアペネムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Meiji Holdings Co., Ltd、 CSPC、 Simcere Pharmaceutical、 Cisen Pharmaceutical、 CHIATAI TIANQING

*************************************************************

・調査・分析レポートの概要
注射用ビアペネム市場の定義
市場セグメント
世界の注射用ビアペネム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の注射用ビアペネム市場規模
世界の注射用ビアペネム市場規模：2022年 VS 2029年
世界の注射用ビアペネム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの注射用ビアペネムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の注射用ビアペネム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：300mg、100mg
注射用ビアペネムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局
注射用ビアペネムの用途別グローバル売上・予測

・地域別市場分析
地域別注射用ビアペネム市場規模 2022年と2029年
地域別注射用ビアペネム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Meiji Holdings Co., Ltd、 CSPC、 Simcere Pharmaceutical、 Cisen Pharmaceutical、 CHIATAI TIANQING
...

This research report provides a comprehensive analysis of the Biapenem for Injection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Biapenem for Injection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Biapenem for Injection, challenges faced by the industry, and potential opportunities for market players.
The global Biapenem for Injection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Biapenem for Injection market presents opportunities for various stakeholders, including Hospital, Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Biapenem for Injection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Biapenem for Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Biapenem for Injection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Biapenem for Injection market.
Market Overview: The report provides a comprehensive overview of the Biapenem for Injection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., 300mg, 100mg), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Biapenem for Injection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Biapenem for Injection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Biapenem for Injection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Biapenem for Injection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Biapenem for Injection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Biapenem for Injection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Biapenem for Injection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Biapenem for Injection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Biapenem for Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
300mg
100mg
Market segment by Application
Hospital
Pharmacy
Global Biapenem for Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Meiji Holdings Co., Ltd
CSPC
Simcere Pharmaceutical
Cisen Pharmaceutical
CHIATAI TIANQING
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biapenem for Injection, market overview.
Chapter 2: Global Biapenem for Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Biapenem for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biapenem for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biapenem for Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Biapenem for Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biapenem for Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biapenem for Injection Overall Market Size
2.1 Global Biapenem for Injection Market Size: 2022 VS 2029
2.2 Global Biapenem for Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biapenem for Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Biapenem for Injection Players in Global Market
3.2 Top Global Biapenem for Injection Companies Ranked by Revenue
3.3 Global Biapenem for Injection Revenue by Companies
3.4 Global Biapenem for Injection Sales by Companies
3.5 Global Biapenem for Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biapenem for Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biapenem for Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biapenem for Injection Players in Global Market
3.8.1 List of Global Tier 1 Biapenem for Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Biapenem for Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Biapenem for Injection Market Size Markets, 2022 & 2029
4.1.2 300mg
4.1.3 100mg
4.2 By Type – Global Biapenem for Injection Revenue & Forecasts
4.2.1 By Type – Global Biapenem for Injection Revenue, 2018-2023
4.2.2 By Type – Global Biapenem for Injection Revenue, 2024-2029
4.2.3 By Type – Global Biapenem for Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Biapenem for Injection Sales & Forecasts
4.3.1 By Type – Global Biapenem for Injection Sales, 2018-2023
4.3.2 By Type – Global Biapenem for Injection Sales, 2024-2029
4.3.3 By Type – Global Biapenem for Injection Sales Market Share, 2018-2029
4.4 By Type – Global Biapenem for Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biapenem for Injection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Biapenem for Injection Revenue & Forecasts
5.2.1 By Application – Global Biapenem for Injection Revenue, 2018-2023
5.2.2 By Application – Global Biapenem for Injection Revenue, 2024-2029
5.2.3 By Application – Global Biapenem for Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Biapenem for Injection Sales & Forecasts
5.3.1 By Application – Global Biapenem for Injection Sales, 2018-2023
5.3.2 By Application – Global Biapenem for Injection Sales, 2024-2029
5.3.3 By Application – Global Biapenem for Injection Sales Market Share, 2018-2029
5.4 By Application – Global Biapenem for Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Biapenem for Injection Market Size, 2022 & 2029
6.2 By Region – Global Biapenem for Injection Revenue & Forecasts
6.2.1 By Region – Global Biapenem for Injection Revenue, 2018-2023
6.2.2 By Region – Global Biapenem for Injection Revenue, 2024-2029
6.2.3 By Region – Global Biapenem for Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Biapenem for Injection Sales & Forecasts
6.3.1 By Region – Global Biapenem for Injection Sales, 2018-2023
6.3.2 By Region – Global Biapenem for Injection Sales, 2024-2029
6.3.3 By Region – Global Biapenem for Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Biapenem for Injection Revenue, 2018-2029
6.4.2 By Country – North America Biapenem for Injection Sales, 2018-2029
6.4.3 US Biapenem for Injection Market Size, 2018-2029
6.4.4 Canada Biapenem for Injection Market Size, 2018-2029
6.4.5 Mexico Biapenem for Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Biapenem for Injection Revenue, 2018-2029
6.5.2 By Country – Europe Biapenem for Injection Sales, 2018-2029
6.5.3 Germany Biapenem for Injection Market Size, 2018-2029
6.5.4 France Biapenem for Injection Market Size, 2018-2029
6.5.5 U.K. Biapenem for Injection Market Size, 2018-2029
6.5.6 Italy Biapenem for Injection Market Size, 2018-2029
6.5.7 Russia Biapenem for Injection Market Size, 2018-2029
6.5.8 Nordic Countries Biapenem for Injection Market Size, 2018-2029
6.5.9 Benelux Biapenem for Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Biapenem for Injection Revenue, 2018-2029
6.6.2 By Region – Asia Biapenem for Injection Sales, 2018-2029
6.6.3 China Biapenem for Injection Market Size, 2018-2029
6.6.4 Japan Biapenem for Injection Market Size, 2018-2029
6.6.5 South Korea Biapenem for Injection Market Size, 2018-2029
6.6.6 Southeast Asia Biapenem for Injection Market Size, 2018-2029
6.6.7 India Biapenem for Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Biapenem for Injection Revenue, 2018-2029
6.7.2 By Country – South America Biapenem for Injection Sales, 2018-2029
6.7.3 Brazil Biapenem for Injection Market Size, 2018-2029
6.7.4 Argentina Biapenem for Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Biapenem for Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Biapenem for Injection Sales, 2018-2029
6.8.3 Turkey Biapenem for Injection Market Size, 2018-2029
6.8.4 Israel Biapenem for Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Biapenem for Injection Market Size, 2018-2029
6.8.6 UAE Biapenem for Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Meiji Holdings Co., Ltd
7.1.1 Meiji Holdings Co., Ltd Company Summary
7.1.2 Meiji Holdings Co., Ltd Business Overview
7.1.3 Meiji Holdings Co., Ltd Biapenem for Injection Major Product Offerings
7.1.4 Meiji Holdings Co., Ltd Biapenem for Injection Sales and Revenue in Global (2018-2023)
7.1.5 Meiji Holdings Co., Ltd Key News & Latest Developments
7.2 CSPC
7.2.1 CSPC Company Summary
7.2.2 CSPC Business Overview
7.2.3 CSPC Biapenem for Injection Major Product Offerings
7.2.4 CSPC Biapenem for Injection Sales and Revenue in Global (2018-2023)
7.2.5 CSPC Key News & Latest Developments
7.3 Simcere Pharmaceutical
7.3.1 Simcere Pharmaceutical Company Summary
7.3.2 Simcere Pharmaceutical Business Overview
7.3.3 Simcere Pharmaceutical Biapenem for Injection Major Product Offerings
7.3.4 Simcere Pharmaceutical Biapenem for Injection Sales and Revenue in Global (2018-2023)
7.3.5 Simcere Pharmaceutical Key News & Latest Developments
7.4 Cisen Pharmaceutical
7.4.1 Cisen Pharmaceutical Company Summary
7.4.2 Cisen Pharmaceutical Business Overview
7.4.3 Cisen Pharmaceutical Biapenem for Injection Major Product Offerings
7.4.4 Cisen Pharmaceutical Biapenem for Injection Sales and Revenue in Global (2018-2023)
7.4.5 Cisen Pharmaceutical Key News & Latest Developments
7.5 CHIATAI TIANQING
7.5.1 CHIATAI TIANQING Company Summary
7.5.2 CHIATAI TIANQING Business Overview
7.5.3 CHIATAI TIANQING Biapenem for Injection Major Product Offerings
7.5.4 CHIATAI TIANQING Biapenem for Injection Sales and Revenue in Global (2018-2023)
7.5.5 CHIATAI TIANQING Key News & Latest Developments
8 Global Biapenem for Injection Production Capacity, Analysis
8.1 Global Biapenem for Injection Production Capacity, 2018-2029
8.2 Biapenem for Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Biapenem for Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biapenem for Injection Supply Chain Analysis
10.1 Biapenem for Injection Industry Value Chain
10.2 Biapenem for Injection Upstream Market
10.3 Biapenem for Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biapenem for Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Biapenem for Injection in Global Market
Table 2. Top Biapenem for Injection Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biapenem for Injection Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biapenem for Injection Revenue Share by Companies, 2018-2023
Table 5. Global Biapenem for Injection Sales by Companies, (K Units), 2018-2023
Table 6. Global Biapenem for Injection Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biapenem for Injection Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Biapenem for Injection Product Type
Table 9. List of Global Tier 1 Biapenem for Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biapenem for Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Biapenem for Injection Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Biapenem for Injection Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biapenem for Injection Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Biapenem for Injection Sales (K Units), 2018-2023
Table 15. By Type - Global Biapenem for Injection Sales (K Units), 2024-2029
Table 16. By Application – Global Biapenem for Injection Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Biapenem for Injection Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biapenem for Injection Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Biapenem for Injection Sales (K Units), 2018-2023
Table 20. By Application - Global Biapenem for Injection Sales (K Units), 2024-2029
Table 21. By Region – Global Biapenem for Injection Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Biapenem for Injection Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biapenem for Injection Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Biapenem for Injection Sales (K Units), 2018-2023
Table 25. By Region - Global Biapenem for Injection Sales (K Units), 2024-2029
Table 26. By Country - North America Biapenem for Injection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biapenem for Injection Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Biapenem for Injection Sales, (K Units), 2018-2023
Table 29. By Country - North America Biapenem for Injection Sales, (K Units), 2024-2029
Table 30. By Country - Europe Biapenem for Injection Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biapenem for Injection Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Biapenem for Injection Sales, (K Units), 2018-2023
Table 33. By Country - Europe Biapenem for Injection Sales, (K Units), 2024-2029
Table 34. By Region - Asia Biapenem for Injection Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biapenem for Injection Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Biapenem for Injection Sales, (K Units), 2018-2023
Table 37. By Region - Asia Biapenem for Injection Sales, (K Units), 2024-2029
Table 38. By Country - South America Biapenem for Injection Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biapenem for Injection Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Biapenem for Injection Sales, (K Units), 2018-2023
Table 41. By Country - South America Biapenem for Injection Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Biapenem for Injection Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biapenem for Injection Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Biapenem for Injection Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Biapenem for Injection Sales, (K Units), 2024-2029
Table 46. Meiji Holdings Co., Ltd Company Summary
Table 47. Meiji Holdings Co., Ltd Biapenem for Injection Product Offerings
Table 48. Meiji Holdings Co., Ltd Biapenem for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Meiji Holdings Co., Ltd Key News & Latest Developments
Table 50. CSPC Company Summary
Table 51. CSPC Biapenem for Injection Product Offerings
Table 52. CSPC Biapenem for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. CSPC Key News & Latest Developments
Table 54. Simcere Pharmaceutical Company Summary
Table 55. Simcere Pharmaceutical Biapenem for Injection Product Offerings
Table 56. Simcere Pharmaceutical Biapenem for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Simcere Pharmaceutical Key News & Latest Developments
Table 58. Cisen Pharmaceutical Company Summary
Table 59. Cisen Pharmaceutical Biapenem for Injection Product Offerings
Table 60. Cisen Pharmaceutical Biapenem for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Cisen Pharmaceutical Key News & Latest Developments
Table 62. CHIATAI TIANQING Company Summary
Table 63. CHIATAI TIANQING Biapenem for Injection Product Offerings
Table 64. CHIATAI TIANQING Biapenem for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. CHIATAI TIANQING Key News & Latest Developments
Table 66. Biapenem for Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 67. Global Biapenem for Injection Capacity Market Share of Key Manufacturers, 2021-2023
Table 68. Global Biapenem for Injection Production by Region, 2018-2023 (K Units)
Table 69. Global Biapenem for Injection Production by Region, 2024-2029 (K Units)
Table 70. Biapenem for Injection Market Opportunities & Trends in Global Market
Table 71. Biapenem for Injection Market Drivers in Global Market
Table 72. Biapenem for Injection Market Restraints in Global Market
Table 73. Biapenem for Injection Raw Materials
Table 74. Biapenem for Injection Raw Materials Suppliers in Global Market
Table 75. Typical Biapenem for Injection Downstream
Table 76. Biapenem for Injection Downstream Clients in Global Market
Table 77. Biapenem for Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biapenem for Injection Segment by Type in 2022
Figure 2. Biapenem for Injection Segment by Application in 2022
Figure 3. Global Biapenem for Injection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biapenem for Injection Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biapenem for Injection Revenue, 2018-2029 (US$, Mn)
Figure 7. Biapenem for Injection Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biapenem for Injection Revenue in 2022
Figure 9. By Type - Global Biapenem for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Biapenem for Injection Revenue Market Share, 2018-2029
Figure 11. By Type - Global Biapenem for Injection Sales Market Share, 2018-2029
Figure 12. By Type - Global Biapenem for Injection Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Biapenem for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Biapenem for Injection Revenue Market Share, 2018-2029
Figure 15. By Application - Global Biapenem for Injection Sales Market Share, 2018-2029
Figure 16. By Application - Global Biapenem for Injection Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Biapenem for Injection Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Biapenem for Injection Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Biapenem for Injection Revenue Market Share, 2018-2029
Figure 20. By Region - Global Biapenem for Injection Sales Market Share, 2018-2029
Figure 21. By Country - North America Biapenem for Injection Revenue Market Share, 2018-2029
Figure 22. By Country - North America Biapenem for Injection Sales Market Share, 2018-2029
Figure 23. US Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Biapenem for Injection Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Biapenem for Injection Sales Market Share, 2018-2029
Figure 28. Germany Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 29. France Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Biapenem for Injection Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Biapenem for Injection Sales Market Share, 2018-2029
Figure 37. China Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 41. India Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Biapenem for Injection Revenue Market Share, 2018-2029
Figure 43. By Country - South America Biapenem for Injection Sales Market Share, 2018-2029
Figure 44. Brazil Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Biapenem for Injection Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Biapenem for Injection Sales Market Share, 2018-2029
Figure 48. Turkey Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Biapenem for Injection Revenue, (US$, Mn), 2018-2029
Figure 52. Global Biapenem for Injection Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Biapenem for Injection by Region, 2022 VS 2029
Figure 54. Biapenem for Injection Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • チオプロニン錠剤のグローバル市場展望 2023年-2029年：100mg、300mg
  • アミノメチル安息香酸注射液のグローバル市場展望 2023年-2029年：5ml:50mg、10ml:100mg
  • 塩酸ミノサイクリン錠剤のグローバル市場展望 2023年-2029年：50mg、100mg
  • 塩酸ミノサイクリンカプセルのグローバル市場展望 2023年-2029年：50mg、100mg
  • メベンダゾール錠のグローバル市場展望 2023年-2029年：100mg、500mg
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14241 )"注射用ビアペネムのグローバル市場展望 2023年-2029年：300mg、100mg" (英文：Biapenem for Injection Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。